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ABSTRACT
Leprosy was rare in Europe during the Roman period, yet its prevalence increased
dramatically in medieval times. We examined human remains, with paleopathological lesions
indicative of leprosy, dated to the 6th–11th century AD, from Central and Eastern Europe and
Byzantine Anatolia. Analysis of ancient DNA and bacterial cell wall lipid biomarkers
revealed Mycobacterium leprae in skeletal remains from 6th–8th century Northern Italy, 7th–
11th century Hungary, 8th–9th century Austria, the Slavic Greater Moravian Empire of the 9th–
10th century and 8th–10th century Byzantine samples from Northern Anatolia. These data were
analyzed alongside findings published by others. M. leprae is an obligate human pathogen
that has undergone an evolutionary bottleneck followed by clonal expansion. Therefore M.
leprae genotypes and sub-genotypes give information about the human populations they have
infected and their migration. Although data are limited, genotyping demonstrates that
historical M. leprae from Byzantine Anatolia, Eastern and Central Europe resembles modern
strains in Asia Minor rather than the recently characterized historical strains from North West
Europe. The westward migration of peoples from Central Asia in the first millennium may
have introduced different M. leprae strains into medieval Europe and certainly would have
facilitated the spread of any existing leprosy. The subsequent decline of M. leprae in Europe
may be due to increased host resistance. However, molecular evidence of historical leprosy
and tuberculosis co-infections suggests that death from tuberculosis in leprosy patients was
also a factor.
Key words
Ancient DNA; Genotyping; human migrations; lipid biomarkers; Mycobacterium leprae;
Mycobacterium tuberculosis
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1. Introduction
Leprosy (Hansen’s Disease) is primarily a disease of peripheral nerves and skin but
also affects bones. In the multi-bacillary lepromatous state there is direct invasion of soft
tissues around the face and mouth by Mycobacterium leprae and spread via the peripheral
nerves to the long bones and extremities. These changes in physical characteristics enabled
the disease to be recognised in antiquity (Skinses and Chang, 1985). Although diagnoses
based only on written reports remain questionable, they suggest that leprosy existed in
ancient times in Egypt, India and China (Lechat, 1999; Mark, 2002). There is possible
skeletal evidence of leprosy from 2000 BC Rajasthan and the late Indus civilisation from
2500–1700 BC (Robbins Schug et al., 2013). The most diagnostic bone changes are found in
the skull, described as the rhinomaxillary syndrome, that involves the destruction of the
anterior nasal spine, the rounding and widening of the nasal margins, the partial resorption of
the pre-maxillary alveolar process and in some cases the loss of the upper incisors (Møller-
Christensen, 1961; Ortner, 2003). Additional changes include deformities of the hands and
feet, which are usually symmetrical and involve joint destruction, resorption of the fingers
and toes, with potentially partial dislocation and bone fusion (Ortner, 2003)
A major difficulty in diagnosing leprosy in skeletal remains is that syphilis may cause
similar changes in the rhinomaxillary region, while psoriatic arthritis, septic arthritis and
other joint diseases may cause identical changes in the hands and feet (Ortner and Putschar,
1985). Hence a clear diagnosis of leprosy based solely on paleopathology can be made only if
the typical facial changes are found in combination with atrophy and truncation of the fingers
and toes. Not all leprosy cases display changes in both the rhinomaxillary region and the
hands and feet, making paleopathological diagnosis difficult. Furthermore, as skeletal
collections often comprise incomplete and damaged bones, paleopathological diagnosis is
likely to overlook many true leprosy cases due to insufficient evidence. As M. leprae is an
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obligate pathogen, its presence in ancient human remains provides clear evidence of infection
(Donoghue et al., 2002). Ancient DNA (aDNA) and/or lipid biomarker analyses enable
identification of M. leprae, thereby confirming the antiquity of the disease. If aDNA
preservation is sufficient, phylogenetic data may be obtained, but analysis is often restricted
to the confirmation of probable leprosy cases, identified by paleopathological features.
Only about 5% of lepromatous leprosy, diagnosed in the 20th century before the
introduction of antibiotics, involved bone changes (Faget and Mayoral, 1942). Therefore, the
number of leprosy cases diagnosed by paleopathology will always be an under-estimate.
However, comparison of the number of leprosy cases based on paleopathology against the
number of skeletons systematically examined for typical lesions for a given period in
antiquity, gives a glimpse of changes in the prevalence rates of the disease over space and
time. In Britain the earliest evidence of leprosy was found in 2/1480 specimens from
Romano-British sites (0.14% prevalence), in 18/2031 specimens from the 5th–11th centuries
AD (0.89% prevalence) and in 108/4742 specimens dated from the 12th–16th centuries (2.28%
prevalence) (Roberts, 2002). This is consistent with the historical accounts and suggests that
the earliest appearance of the disease in Europe occurred during the Roman period (Pinhasi et
al., 2006).
A major historic transition occurred when early Eurasian civilizations came into
military and commercial contact some 1500–3000 years ago (McMichael, 2001; 2004). The
east-west trade route, known as the Silk Road, was a means of spreading infections to and
from China, the Eastern Mediterranean and Rome, to previously unexposed populations,
including malaria, bubonic plague, leprosy, measles and smallpox. For example, McMichael
(2001) states that smallpox entered the Roman Empire via troops returning from Syria in the
second century AD. Mark (2002) suggested that the troops of Alexander the Great brought
leprosy from eastern Asia to the Mediterranean, leading to its spread on a larger scale in
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Europe during the fourth century BC.
Skeletal cases with evidence of pathological lesions that are consistent with leprosy
were reported from 4th–3rd century BC Bologna, Italy (Mariotti et al., 2005) and 2nd century
BC Roman Egypt (Molto, 2002). A case of lepromatous leprosy from mummified remains in
early Christian Nubia (Elliot Smith and Dawson, 1924) and there are several reported cases
from the Byzantine period (Zias, 1985). A child with characteristic leprosy paleopathology
was found in Martellona (Rome, Central Italy), dated to the 2nd–3rd century AD (Rubini et al.,
2012). An adult from Palombara, a poor rural site near Rome, Central Italy, showed
paleopathology of the rhinomaxillary region typical of leprosy (Rubini et al., 2014). This case
was C14-dated to 475 ± 25 years CE (5th century AD).  Among other early cases, Reader
(1974) reported changes suggestive of leprosy in the right foot of an incomplete adult
skeleton from a 4th century AD Romano-British cemetery. Also, a case from the Roman Iron
Age (0–400 AD) has been reported in Sweden (Arcini and Artelius, 1993 cited by Kjellström,
2010). Hence, there is sporadic evidence of leprosy in the ‘Roman World’ that may have
extended west to southern Britain and north to southern Sweden.
The diagnosis of M. leprae in specimens using both paleopathological diagnosis and
aDNA analysis was first reported by Rafi et al. (1994) in archaeological skeletal samples
from early Christian Palestine (600 AD). The earliest case confirmed by aDNA analysis, also
from the Eastern Mediterranean, was dated to the 1st century AD (Donoghue et al., 2005a;
Matheson et al., 2009). The M. leprae genome contains several repetitive sequences that
enable the identification of the organism. Single nucleotide polymorphisms (SNPs) form the
basis of molecular typing (Monot et al., 2005). There appears to be a clonal relationship
between M. leprae and its human host, so determination of the genetic profiles of modern and
extinct strains of M. leprae can illuminate the migration and spread of pathogen and host over
time (Monot et al., 2009; Economou et al., 2013; Schuenemann et al., 2013; Taylor et al.,
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2013; Mendum et al., 2014). Archaeological studies indicate that the first significant
appearance of leprosy occurred in northern Europe during the 9th –11th century AD
(Schuenemann et al., 2013; Taylor et al., 2013). In Britain, the increase of lazar house
foundations for the care of leprosy patients was maximal during the 12th and early 13th
centuries (Manchester and Roberts, 1989). During the 15th-16th centuries the disease nearly
disappeared from southern Europe and Britain, possibly linked to the increased level of
tuberculosis in the community (Manchester, 1984).
Much less is known about the appearance and spread of leprosy in Eastern Europe
and Western Asia. The paleopathological study by Blau & Yagodin (2005a) indicates
evidence of leprosy from a nomadic burial mound located in the Ustyurt Plateau, Uzbekistan,
radiocarbon dated to 80-240 AD (OxA-11792 on human tooth, 2 sigma) (Blau and Yagodin,
2005b). This suggests that leprosy prevailed among nomadic central Asian people and that
one or more of these Asian populations may have either introduced leprosy for the first time
in Eastern Europe by the 6-8th century AD, or possibly re-introduced it as a later wave
following the Roman period spread of the disease across Europe. However, there is a lack of
evidence of leprosy from the skeletal population in the eastern parts of the Roman Empire,
such as Croatia, where the earliest historical report of the disease was 804 AD and linked to
contact with Byzantium (Bakija-Konsuo and Mulić, 2011).
The movement of peoples from Central Asia into the Great Hungarian Plain (Holló et
al., 2008) and Northern Italy (Rubini and Zaio, 2011) may be relevant in relation to the
spread of leprosy. Cases recognised by paleopathology were reported from cemeteries in 6th-
8th century Central Italy (Belcastro et al., 2005; Rubini and Zaio, 2009) and from a 10th
century cemetery in Eastern Hungary (Palfí, 1991).  Later, combined paleopathological and
aDNA studies of specimens from early medieval sites in Eastern Hungary (Haas et al., 2000;
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Csóri et al., 2009) and southern Hungary (Donoghue et al., 2005a) confirmed that the disease
existed in Eastern Europe during this period.
A key to our understanding of spatio-temporal changes in disease patterns is the
identification of new leprosy cases from well-dated archaeological contexts and their
differential diagnosis, using both paleopathological and molecular methods (Donoghue et al.,
2005a; Minnikin et al., 2011). The present study focuses on the confirmation of leprosy in
Northern Anatolia, Eastern and Central Europe, during the 6th-11th centuries AD and the
molecular characterisation of M. leprae. This was achieved by collating earlier results and
systematically assessing the presence of leprosy in eight Avar period cemeteries, six Early
Mediaeval sites, and a Byzantine North Anatolian cemetery.
2. Materials and Methods
2.1. Paleopathological assessment
Specimens analyzed originated from Austria, the Czech Republic, Hungary, Italy and
Turkey, dated from the 6th-8th to the 11th centuries (Table 1). Further details and descriptions
of the additional archaeological sites and burials are available as electronic supplementary
material S1.  Possible leprosy cases were first identified according to established
paleopathological signs (S1 supplementary text and figures) and were assessed using standard
macroscopic methods.
2.2. Molecular analysis
Taking strict precautions against contamination (supplementary material S2), DNA
extracts were made for all specimens with pathological conditions consistent with infection
by the pathogen. M. leprae multi-copy and single-copy loci were amplified by PCR, with
independent laboratories to provide verification of data, using established methods for
paleomicrobiological analysis (S2 Table 1) based on the repetitive sequences RLEP
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(Donoghue et al., 2001; 2005a; Taylor et al., 2011) and RepLep. Better-preserved samples
were genotyped (Monot et al., 2005) according to three single nucleotide polymorphisms
(SNPs) and sub-genotyped, where possible (Monot et al, 2009; Taylor et al., 2006; 2013).
Strains were further distinguished by microsatellite analysis (Taylor and Donoghue, 2011;
Taylor et al., 2013). M. leprae cell wall lipid biomarkers (supplementary text and figures S3)
were used to provide independent confirmation of aDNA findings (Redman et al., 2009; Lee
et al., 2012). Several specimens were also examined for the presence of M. tuberculosis
aDNA (supplementary text and Table S2).
Results
A detailed paleopathological macroscopic analysis of putative leprosy cases, together
with an assessment of published cases, identified material for molecular examination
(supplementary text and figures S1). M. leprae DNA was found in specimens at all sites,
including seven from Hungary, two sites from Italy, and one site each from Austria, the
Czech Republic and Turkey (Table 1). The timescale ranged from the 6th–8th to the 11th
centuries. In several specimens M. tuberculosis aDNA was also detected, confirming earlier
findings of such co-infections (Donoghue et al., 2005a).
Genotyping was successfully performed for M. leprae DNA (supplementary text and
figures S2) obtained from 7th century Hungary, 8th –9th century Turkey, 9th–10th century
Czech Republic and 10th century Hungary. All were of SNP-type 3. This is associated in the
modern day with strains from Europe, North Africa, the Far East and the Americas (Monot et
al., 2005, 2009; Weng et al., 2013). Where sub-genotyping was possible, the Hungarian and
Byzantine samples from the 7th–10th centuries were of subtype 3K. Two samples, from 9th–
10th century Czech Republic and 10th century Hungary were of subtype 3M (Table 1).
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Two samples from Hungary, from the 10th century, plus one sample from the Czech
Republic (9th–10th century), each yielded unique microsatellite data that indicates the
excellent state of preservation of these specimens (Taylor and Donoghue, 2011). The M.
leprae DNA from the two individuals in the adjoined Hungarian burial site of Püspökladány–
Eperjesvölgy differed in the number of TTC repeats, having 12 and 17 copies respectively.
Interestingly, these two 10th-century M. leprae strains were of different sub-genotypes, 3K
and 3M. Therefore, different sub-genotypes of M. leprae were contemporaneous in the same
burial ground. This has also been noted in burial grounds from North West Europe, where
individuals with M. leprae genotypes 2F or 3I were identified (Economou et al., 2013; Taylor
et al. 2013).
M. leprae cell wall lipids appear to be more persistent than aDNA, as shown by the
data from 7th century Vicenne, Italy, where no aDNA but lipid biomarkers were found in a
well-developed case of leprosy in specimen 144 (Table 1 and supplementary text and figures
S3). Strong, coherent profiles of total mycolic acids were recorded for specimens 18R, 18L
and 144, but they differed slightly from the modern M. leprae standard (S3 Fig. 1). The
profiles of the purified α-mycolates were again coherent, but the overall profiles were
essentially four carbons shorter than those from standard M. leprae (S3 Fig. 2). In contrast,
the more robust mycocerosates showed an excellent profile of C30 to C34 mycocerosates for
specimen 18R (S3 Fig. 3), corresponding closely with the M. leprae standard (S3 Fig. 4). The
same mycocerosates, typical of M. leprae, were seen for 18L and 144, but with much reduced
intensity (S3 Fig. 3).
Discussion
Geographical analysis shows that regions, apparently endemic for leprosy, are
associated with migrations linked with military activity and aggressive expansion of
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territories, or of colonization (Buzhilova, 2002).  Early sporadic reports of leprosy in Western
Europe (Manchester, 1984; Lechat, 1999; Brothwell et al., 2000; Blondiaux et al., 2002) are
believed to be associated with Roman armies and traders. The premise that leprosy originated
in the East and came to Egypt via seaborne trade during this period is discussed by Mark
(2002) who thought that this was more likely than the widely-held belief that the disease was
brought back by the armies of Alexander the Great (Dols, 1979; Monot et al., 2005). After
the fall of the Roman Empire there was an expansion westwards of peoples from Central
Asia. The Avars, believed to belong to the Juan-Juan confederation of Mongolian pastoralist
tribes, emerged in the 4th century AD (Zhang and Rong, 1998) and spread into Eastern and
Central Europe (Fig. 1). Diagnosis of leprosy in 1st–4th century AD Uzbekistan (Blau and
Yagodin, 2005a,b), using paleopathology and subsequent molecular analysis (Taylor et al.,
2009), demonstrates the antiquity of leprosy in Central Asia and suggests that the disease
could have been spread by the Avars, resulting in the appearance of leprosy in Hungary,
Eastern Austria and Italy. Another possibility is that the Avars played a role in the spread of
indigenous leprosy from Asia Minor to Eastern and Central Europe. Leprosy was a disease
known in Byzantium (Dols, 1979) and a gold Byzantine solidus was recovered from Grave
21 in Kiskundorozsma-Daruhalom, Hungary. This represents the latest coin of the series
issued under Constans II (Constans II, MIB 39, AD 667—668). Thus there is circumstantial
evidence to suggest that males of this Avar community had contacts with the Byzantine
Empire (Donoghue et al., 2005b). This coin was probably minted for about a year, and it is
thus reasonable to assume that the journey occurred sometime in the late AD 660’s or early
AD 670’s.
Following their arrival in the Byzantine Empire and southeast Europe, the Avars
migrated westwards and clashed with the kingdom of the Franks. There is both historical and
archaeological evidence of Avar occupation in the area at this time, and that they formed
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alliances with local Slavs. The case from the 9th century Czech Republic (Taylor and
Donoghue, 2011) is relevant as it is from the Slavic Greater Moravian Empire, known to have
fought both alongside and against the Avars, thereby providing means of spread of the
disease. The confirmation of several cases of leprosy identified by skeletal paleopathology,
reported from 7th–9th century AD Avar settlements in Hungary (Marcsik et al., 2009; Palfí
and Molnár, 2009), is the earliest report of the disease in this region. Similarly, the finding of
M. leprae DNA in an 8th–9th century Austrian sample pre-dates all other known cases of
leprosy in that country.
Leprosy has also been found in 6th–8th century Italy. The leprosy case from the 7th
century cemetery of Vicenne-Campochairo, Italy was from a Barbarian complex with
Lombard, local and Asian grave goods (Belcastro et al., 2005). Rubini & Zaio (2009)
described two burials with leprosy paleopathology in a cemetery attributed to a semi-nomadic
Lombard-Avar group. Both sites may have represented military outposts to control the area
against Byzantine invasions. The present biomolecular study confirms M. leprae at both sites.
The molecular confirmation of M. leprae in 8th – 9th century Croatia (Watson et al., 2009) is
consistent with the earliest historical report of leprosy at this location in 804 AD (Bakija-
Konsuo and Mulíc, 2011), especially as it is suggested that the disease resulted from contact
with Byzantium.
A 4th century sample from the Dakhleh Oasis in Roman Egypt was of genotype 3
(Monot et al., 2005), the same main branch as those linked to the Avar expansion, although it
was not possible to determine the sub-genotype. The earliest M. leprae to be sub-genotyped,
from 1st– 4th century Uzbekistan, was of subtype 3L (Taylor and Donoghue, 2011). It is of
interest that the predominant sub-genotype in the earlier Hungarian samples was 3K, identical
to the leprosy found in Byzantine Anatolia (Table 1) and the main sub-genotype found today
in Turkey and the near East (Monot et al., 2009). Two Hungarian samples from the 9th and
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10th centuries were of type 3M. Recent whole genome sequencing indicates that 3K strains
may form a separate branch of the M. leprae phylogenetic tree (Schuenemann et al, 2013),
termed branch 0. However, that study was primarily based on strains from Northern and
Western Europe, and included only two 3K strains that were from modern China and New
Caledonia. Therefore, further work is needed to clarify the phylogeny of the type 3 sub–
genotypes. Overall, our biomolecular diagnosis of early cases of leprosy from Hungary,
Austria, the Czech Republic, Italy, Croatia, and Turkey suggests that the migration of the
Avars from Central Asia into Byzantium and Central Europe was associated with a further
wave of leprosy in local populations not previously exposed to the disease.
The few sub-genotypes obtained from Northern and Western Europe are 3I or 2F
(Economou et al., 2013; Schuenemann et al., 2013; Taylor et al., 2013; Mendum et al., 2014).
These genotypes are from at least two lineages that were associated with the Mediaeval rise
in leprosy described in North West Europe and appear to be associated with Nordic and
Saxon populations. However, more work is needed to confirm this. The 3I lineage is of
special interest as it has been reported in a later medieval burial (Taylor et al., 2009) and is
still found in the southern states of the USA (Truman et al., 2011), whence it was probably
carried by early European settlers.
The subsequent decline of leprosy in Western Europe cannot readily be explained.
Recent analyses of whole genomes retrieved from several European archaeological sites and
their comparison with modern isolates (Schuenemann et al., 2013) found no obvious
mutations in genes related to virulence or pathogenesis, and no additional pseudogenes in the
ancient genomes. Considering host susceptibility, people with leprosy have an impaired
immune status, and thus may have been more prone to other infections. This could have
included epidemics such as the European 14th century outbreak of the Black Death, caused by
Yersinia pestis and believed to have killed between one and two-thirds of the European
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population, including two million people in England. It is likely that the Black Death
adversely afflicted the social support networks of leprosaria, such as the clergy, individual
patrons and physicians. Under such conditions, the suggestion has arisen that a subsequent
improvement in socio-economic conditions, coupled with the innate resistance of the
surviving population, resulted in a shift to the tuberculoid end of the disease spectrum in
those exposed to leprosy (Manchester, 1984). Additionally, it is probable that the increased
urbanisation and population density that occurred from the late 15th century resulted in
tuberculosis killing leprosy patients (Donoghue et al., 2005a). Either of these two factors
could break the transmission of infection. Epidemiological analysis shows that both theories
are feasible (Hohmann and Voss-Böhme. 2013).
In conclusion, the genotyping data currently available support the suggestion that
different M. leprae strains from Central Asia or Asia Minor were introduced into Europe
during the early medieval period, associated with the westward migration of Avars. However,
more evidence is needed to determine whether microbial virulence or host factors were
responsible for the subsequent large rise in the incidence of leprosy in Europe and its
subsequent decline.
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Figure 1
Location of archaeological sites listed in Table 1.
Table 1
Summary of age and geographical location of burial sites, details of specimens examined
and molecular biomarkers detected.
  
23
  
Table 1.  
Country and site 
 
Burial  
No. 
 
Age at 
death 
Sex Samples Century  
(AD) 
M. leprae 
DNA 
SNP type M. leprae 
lipids 
MTB
1
 DNA 
 
Hungary 
Lászlófalva- 
Szentkirály 
 
79 35–45 M Rib 
Tarsus 
11
th
 +  
+ 
 + + 
Hungary 
Felgyő, 
Kettőshalmi-dűlő 
2467 35–39 F Nasal 11th –   + 
 
3658 elderly M Tibia +    
Hungary 
Püspökladány- 
Eperjesvölgy 
 
11 55-60 F Nasal 10
th
  +    
222 22-40 M Nasal 10
th
  + 
 
3K 
 
 + 
429 50-55 M Nasal 11
th
  +    
503 30–35 F Nasal 10th  + 3M + + 
Hungary  
Sárrétudvari-Hízóföld 
 
S202 
 
50–60 F Metatarsal 10th  –    
 
 
S237a 
S237b 
middle- 
aged 
M Palate 
Metatarsal 
10
th
  + 
– 
   
Hungary 
Hajdúdorog-Gyúlás 
 
HG-56 mature M Palate 10
th
  +   + 
Table(s)
  
Czech Republic 
Prušanky 
188 12-15 M Nasal 
Fibula 
Arm 
Rib 
9
th
 – 10th  + 
+ 
+ 
± 
3M   
Austria 
Zwölfaxing 
70  
 
65-70 F 
 
Palate & 
Rib 
8
th
 – 9th +    
 
88  
 
25-30 M Palate & 
Rib 
+   + 
Croatia 
Radasinovci 
(Watson et al., 2009) 
 
2A 50-60 M Rhino- 
maxillary 
8
th
 – 9th  + 3   
 
3A 20-25 F + 3   
Turkey 
Kovuklukaya 
9/1 4–5 m - Skull 8
th
 – 9th +    
11/2 40-50 M Nasal –    
20/1 35-45 F Nasal + 3K   
24/1 30-35 M Nasal  +  +  
Hungary 
Szarvas Grexa 
SG38 30-35 F Rhino- 
maxillary 
late 7
th
 – 
9
th
 
+  + 
 
Hungary 
Bélmegyer- 
Csömöki domb 
BC-51 23-25 M Maxilla/ 
Nasal 
7
th
 –9th  +    
  
Hungary 
Szentes-Kistőke 
SK11 adult F Maxilla/ 
Nasal 
7
th – 8th  +    
 
Italy 
Vicenne 
T18 Young 
adult 
F Nasal  
Tibia 
mid-late 
7
th
  
+ 
+ 
 +  
 
T31 Mature F Maxilla –    
T144 20-25 M Tibia –  +  
Hungary 
Szeged- 
Kiskundorozsma- 
Daruhalom dűlő II 
KD271 50-60 M Palate 7
th
  + 3K   
KD517 35-40 M Nasal +  + + 
KD518 40-45 M Nasal +    
Italy 
Morrione 
T68 46-48 F Maxilla 
Nasal 
Rib 
6
th
 – 8th  – 
– 
– 
  
 
T108 50-55 M Maxilla 
Nasal 
Rib 
+ 
– 
+ 
  
Uzbekistan 
Devkesken 6 
5b adult F Skull 
Left tibia 
1
st
 – 4th  + 
+ 
3L + 
 
 
1
MTB M. tuberculosis 
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Highlights
· 32 skeletal remains from 16 sites in 7 countries had physical evidence of
leprosy
· 26 individuals harbored Mycobacterium leprae ancient DNA and/or lipid
biomarkers
· Avars from Central Asia were linked with 6th-8th century European
leprosy burials
· We confirmed the earliest known leprosy cases in Southern Hungary and
Austria
· Ancient DNA showed that six individuals had leprosy co-infected with
tuberculosis
